Sign in

CIK 0001746466 · Non-accelerated filer<br>Smaller reporting company

Equillium, Inc.

Sign in to watch
Ticker
EQ
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
821554746
Phone
(858) 412-5302
Business address
2223 AVENIDA DE LA PLAYA, SUITE 105, LA JOLLA, CA, 92037
  1. 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Regulation FD disclosure · Other events
  2. 4 Open-market sale Chief Financial Officer sold 5,000 shares at $3.60 ($17,981)
  3. 10-Q Report Quarterly Report
  4. 8-K Event Results of operations
  5. 4 Open-market sale Chief Financial Officer sold 5,000 shares at $3.99 ($19,941)
  6. SC 13G Stake Amended Statement of Ownership
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 8-K Event Shareholder vote results
  12. S-8 POS Other Post-effective Amendment
  13. 10-Q Report Quarterly Report
  14. 8-K Event Results of operations
  15. 8-K Event Regulation FD disclosure
  16. DEF 14A Proxy Proxy Statement
  17. S-8 Other Securities Offered to Employees in Benefit Plans
  18. 10-K Report Annual Report
  19. 8-K Event Results of operations
  20. 8-K Event Results of operations · Regulation FD disclosure · Other events

Page 21 of 24 · 469 filings